Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Loop Health vs Luma Health Co

Loop Health
Graded #112

Lower grade

vs+4.799999999999997
Luma Health Co
Graded #62

Higher grade

The verdict

Luma Health Co takes it — 74.8/100 to 70/100.

Luma Health Co grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Luma Health Co is a nurse-practitioner-led virtual weight-loss and wellness clinic founded by Tiffani McKnight, FNP-C.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLoop Health +11
79
68
Dose & formulationLuma Health Co +5
64
69
Clinical oversightLuma Health Co +4
79
83
Labs & monitoringLuma Health Co +24
73
97
FulfillmentLuma Health Co +8
62
70
Contract termsLuma Health Co +14
41
55
Loop Health · left barLuma Health Co · right bar

The numbers

MetricLoop HealthLuma Health Co
WeighScore70/10074.8/100
GradeCC
Scorecard rank#112#62
Semaglutide$79/mo (plus a separate fee, compounded)$120/mo (plus a separate fee, compounded)
Tirzepatide$125/mo (annual plan, plus a separate fee, compounded)$180/mo (compounded)
CoverageCoverage not published30 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Loop Health

Graded #112 · C

Strengths

  • Multi-product wellness platform — GLP-1 plus peptides, NAD+, coaching, bloodwork
  • Low membership entry point ($79/mo)
  • Annual plan includes monthly 'research credit' toward compounds
  • Explicit compounded-drug FDA disclaimer on-site

Where it loses points

  • Per-dose GLP-1 drug pricing not transparent on public site (compounds billed separately by pharmacy)
  • States-served list not enumerated — only 'select U.S. states'
  • Platform explicitly 'is not a healthcare provider' — relies on independent provider network
  • No LegitScript number disclosed on homepage
Luma Health Co

Graded #62 · C

Strengths

  • Transparent, competitive pricing published up front — compounded semaglutide from $120/mo, tirzepatide from $180/mo, retatrutide from $170/mo
  • No subscription, monthly fee or membership — a direct-to-patient model where you pay per medication, and follow-up visits are free
  • Free initial consults for first responders, law enforcement, military, nurses and teachers ($0), and $25 for other healthcare workers
  • Founded and led by a named family nurse practitioner (Tiffani McKnight, FNP-C) licensed across 30 states/DC, with HIPAA-compliant virtual visits
  • HSA/FSA funds and financing accepted, with itemized invoices for HSA/FSA submission

Where it loses points

  • Offers compounded retatrutide (labeled "RTT/GLP-3"), an investigational triple agonist not FDA-approved — a higher-risk, less-studied option
  • Compounded medications only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
  • No LegitScript certification shown and no compounding-pharmacy partner named, so the dispensing pharmacy can't be independently verified
  • Small, newly established founder-led practice with a thin website and limited public track record or third-party reviews
  • Medication prices are "starting at" and billed on top of a one-time consult fee, so the true first-month cost runs higher than the headline

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard